Synthesis, Anti-Microbial Evaluation and Structure Activity Relationship (SAR) Studies of Some 1-phenyl-3-(5-phenyl-1H-imidazol-1-yl) thiourea Derivatives / Rohit Singh, Swastika Ganguly
Introduction: A series of seventeen 1-phenyl-3-(5-phenyl-1H-imidazol-1-yl) thiourea derivatives (5a-8d) were synthesized and characterized by physical and spectral data (IR, 1H NMR, and mass spectroscopy) and evaluated for their antibacterial and antifungal activities against various pathogenic and non-pathogenic microorganisms. Some of the synthesized compounds showed promising antibacterial and antifungal activities. Results and Discussions: Many of the tested compounds were found to be significantly active against gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis) and gram-negative bacterial strains (Escherichia coli, Salmonella typhi, Klebsiella pneumoniae and Pseudomonas aeruginosa), among which compounds 5a, 5b, 6a, 6b, 7a, 7b, 8a and 8b showed the maximum anti-bacterial activity but less effective than the standard ciprofloxacin. Almost all compounds from 5a-8d showed moderate activity against fungal strains like Candida albicans and Aspergillus niger.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Anti-infective agents - 16(2018), 1, Seite 64- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Singh, Rohit [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (7 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL008994137 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL008994137 | ||
| 003 | DE-627 | ||
| 005 | 20231129085831.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220323s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL008994137 | ||
| 035 | |a (KFL)prod_DARH_.31145C9563B6FFE9D7087A977DFDAEC77B85006C | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Singh, Rohit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synthesis, Anti-Microbial Evaluation and Structure Activity Relationship (SAR) Studies of Some 1-phenyl-3-(5-phenyl-1H-imidazol-1-yl) thiourea Derivatives |c Rohit Singh, Swastika Ganguly |
| 264 | 1 | |c 2018 | |
| 300 | |a 1 Online-Ressource (7 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Introduction: A series of seventeen 1-phenyl-3-(5-phenyl-1H-imidazol-1-yl) thiourea derivatives (5a-8d) were synthesized and characterized by physical and spectral data (IR, 1H NMR, and mass spectroscopy) and evaluated for their antibacterial and antifungal activities against various pathogenic and non-pathogenic microorganisms. Some of the synthesized compounds showed promising antibacterial and antifungal activities. Results and Discussions: Many of the tested compounds were found to be significantly active against gram-positive bacteria (Staphylococcus aureus and Bacillus subtilis) and gram-negative bacterial strains (Escherichia coli, Salmonella typhi, Klebsiella pneumoniae and Pseudomonas aeruginosa), among which compounds 5a, 5b, 6a, 6b, 7a, 7b, 8a and 8b showed the maximum anti-bacterial activity but less effective than the standard ciprofloxacin. Almost all compounds from 5a-8d showed moderate activity against fungal strains like Candida albicans and Aspergillus niger | ||
| 700 | 1 | |a Ganguly, Swastika |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-infective agents |d Sharjah : Bentham Science, 2012 |g 16(2018), 1, Seite 64- |h Online-Ressource |w (DE-627)KFL000006572 |w (DE-600)2856689-0 |w (DE-576)469947063 |x 2211-3533 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2018 |g number:1 |g pages:64- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=2211-3525&volume=16&issue=1&spage=64 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_DARH_01 | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2018 |e 1 |h 64- | ||